Skip to content

Efficacy Testing of Melon Oil Olive Pressed Candy Products

Efficacy Testing of Melon Oil Olive Pressed Candy Products

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05988567
Enrollment
60
Registered
2023-08-14
Start date
2023-05-09
Completion date
2023-12-31
Last updated
2024-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Condition

Brief summary

To assess melon and oil olive pressed candy on skin condition improvement

Interventions

DIETARY_SUPPLEMENTPlacebo candy

consume 2 tablets per day

DIETARY_SUPPLEMENTmelon and oil olive pressed candy

consume 2 tablets per day

Sponsors

TCI Co., Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Healthy adults aged above 18 years old * ITA° value 20°-41°

Exclusion criteria

* Involuntary subjects. * Subjects who have a history of skin diseases such as psoriasis, eczema, atopic dermatitis, severe acne; or suffer from other chronic systemic disease. * Those with known cosmetic, drug or food allergies. * Female who is pregnant or nursing or planning to become pregnant during the course of the study. * Subjects who have taken oral or topical corticosteroids and other anti-inflammatory drugs in the past 1 month. * Use of any products or drugs that affect skin color such as fruit acid, salicylic acid (such as Hydroquinone preparations) in the past 2 months. * In the past 3 months, the test site has used retinoic acid preparations or undergone chemical peeling, laser, pulse light and other medical aesthetic therapists * Subjects who can not avoid long-term sun exposure

Design outcomes

Primary

MeasureTime frameDescription
The change of skin brown spotsChange from Baseline skin brown spots at 12 weeksVISIA Complexion Analysis System was utilized to measure skin brown spots. Units: arbitrary units
The change of skin b* valueChange from Baseline b* value at 12 weeksChroma Meter MM500 was utilized to measure skin b\* value. Units: arbitrary units
The change of skin ITA° valueChange from Baseline ITA° value at 12 weeksChroma Meter MM500 was utilized to measure skin ITA° value. Units: arbitrary units
The change of skin spotsChange from Baseline skin spots at 12 weeksVISIA Complexion Analysis System was utilized to measure skin spots. Units: arbitrary units
The change of skin UV spotsChange from Baseline skin UV spots at 12 weeksVISIA Complexion Analysis System was utilized to measure skin UV spots. Units: arbitrary units
The change of skin wrinklesChange from Baseline skin wrinkles at 12 weeksVISIA Complexion Analysis System was utilized to measure skin wrinkles. Units: arbitrary units
The change of skin textureChange from Baseline skin texture at 12 weeksVISIA Complexion Analysis System was utilized to measure skin texture. Units: arbitrary units
The change of skin melanin indexChange from Baseline skin melanin index at 12 weeksMexameter® MX18 was utilized to measure skin melanin index. Units: arbitrary units
The change of skin erythema indexChange from Baseline skin erythema index at 12 weeksMexameter® MX18 was utilized to measure skin erythema index. Units: arbitrary units
The change of skin L* valueChange from Baseline L* value at 12 weeksChroma Meter MM500 was utilized to measure skin L\* value. Units: arbitrary units

Secondary

MeasureTime frameDescription
The change of TEAC of bloodChange from Baseline TEAC at 12 weeksVenous blood was sampled to measure TEAC
The change of SOD of bloodChange from Baseline SOD at 12 weeksVenous blood was sampled to measure SOD
The change of GSH-Px of bloodChange from Baseline GSH-Px at 12 weeksVenous blood was sampled to measure GSH-Px

Other

MeasureTime frameDescription
The change of self-assessment skin and hair conditionChange from Baseline skin and hair condition at 12 weeksA self-assessment questionnaire was collected to evaluate skin and hair condition

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026